JP2002533096A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533096A5
JP2002533096A5 JP2000589732A JP2000589732A JP2002533096A5 JP 2002533096 A5 JP2002533096 A5 JP 2002533096A5 JP 2000589732 A JP2000589732 A JP 2000589732A JP 2000589732 A JP2000589732 A JP 2000589732A JP 2002533096 A5 JP2002533096 A5 JP 2002533096A5
Authority
JP
Japan
Prior art keywords
allele
pattern
kit
primer
oligonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000589732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533096A (ja
Filing date
Publication date
Priority claimed from US09/183,850 external-priority patent/US6251598B1/en
Application filed filed Critical
Publication of JP2002533096A publication Critical patent/JP2002533096A/ja
Publication of JP2002533096A5 publication Critical patent/JP2002533096A5/ja
Pending legal-status Critical Current

Links

JP2000589732A 1998-10-30 1999-11-01 敗血症の診断法および治療法 Pending JP2002533096A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/183,850 1998-10-30
US09/183,850 US6251598B1 (en) 1998-10-30 1998-10-30 Methods for diagnosing sepsis
PCT/US1999/025633 WO2000037679A2 (en) 1998-10-30 1999-11-01 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis

Publications (2)

Publication Number Publication Date
JP2002533096A JP2002533096A (ja) 2002-10-08
JP2002533096A5 true JP2002533096A5 (enExample) 2007-07-19

Family

ID=22674558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000589732A Pending JP2002533096A (ja) 1998-10-30 1999-11-01 敗血症の診断法および治療法

Country Status (10)

Country Link
US (2) US6251598B1 (enExample)
EP (1) EP1127168B1 (enExample)
JP (1) JP2002533096A (enExample)
AT (1) ATE403745T1 (enExample)
AU (1) AU779772B2 (enExample)
CA (1) CA2346960A1 (enExample)
DE (1) DE69939269D1 (enExample)
ES (1) ES2308861T3 (enExample)
IL (1) IL142438A0 (enExample)
WO (1) WO2000037679A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
AU2001263373A1 (en) * 2000-09-20 2002-04-02 Genaissance Pharmaceuticals, Inc. Haplotypes of the il1b gene
US20040028651A1 (en) * 2001-03-29 2004-02-12 Karrupiah Muthumani Composition and methods of using hiv vpr
KR20050034584A (ko) * 2001-10-05 2005-04-14 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Sirs/패혈증의 치료 및 예방 방법 및 이를 위한조성물
EP1463745A4 (en) * 2001-11-19 2007-11-07 Interleukin Genetics Inc FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 SITE AFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TO INFLAMMATORY AND INFECTIOUS DISEASES
US20080311581A1 (en) * 2001-11-19 2008-12-18 David Wyllie Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
MXPA05005072A (es) * 2002-11-12 2005-07-22 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
CA2505921A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
WO2005038427A2 (en) * 2003-06-05 2005-04-28 Medical Gene Center Ltd. Rapid identification of viruses of the upper respiratory tract infection including sars causing coronus viruses
CN1882705A (zh) * 2003-10-06 2006-12-20 诺瓦提斯公司 遗传多态性用于预测药物诱导肝脏毒性的用途
EP1725574A4 (en) * 2004-03-04 2008-10-29 Univ British Columbia THROMBOMODULIN (THBD) HAPLOTYPES AS RESULTS INDICATORS FOR PATIENTS
EP1723160A4 (en) * 2004-03-04 2008-04-23 Univ British Columbia FORECAST OF PATIENT STATUS EVOLUTION USING TOLL-RECEPTOR 2 (TLR-2) HAPLOTYPES
US8034553B2 (en) * 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
EP1851245B1 (en) 2005-01-26 2012-10-10 Amgen Fremont Inc. Antibodies against interleukin-1 beta
RU2286154C2 (ru) * 2005-02-17 2006-10-27 Владимир Алексеевич Шатров Способ лечения воспалительных заболеваний головного мозга
US8293521B2 (en) 2005-03-30 2012-10-23 Shimadzu Corporation Method of dispensing nonvolatile liquid in reaction vessel and reaction vessel processing apparatus
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
WO2010070136A2 (en) * 2008-12-19 2010-06-24 Centre de Recherche Public de la Santé Novel caviidae allergens and uses thereof
EP2676675B1 (en) 2011-02-18 2019-04-10 Stemdr Inc. Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
US10126305B2 (en) 2013-06-25 2018-11-13 University of Pittsburg—Of the Commonwealth System of Higher Education Proteomic biomarkers of sepsis in elderly patients
CA3011363A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CA3142662A1 (en) 2019-06-06 2020-12-10 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
CA2081774A1 (en) 1990-05-01 1991-11-02 John Stephen Haskill Interleukin-1 antagonist and uses thereof
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
DE4408890A1 (de) 1994-03-16 1995-09-21 Knoll Ag Verwendung von Il-1-Antagonisten als Arzneimittel zur Behandlung von Erkrankungen mit einem erhöhten Interleukin-6 Serumspiegel
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5942390A (en) * 1996-01-12 1999-08-24 Cedars-Sinai Medical Center Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
AU2213697A (en) 1996-03-18 1997-10-10 Medical Science Systems, Inc. A method for periodontal disease treatment
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6210877B1 (en) 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
IL135957A0 (en) 1997-11-07 2001-05-20 Interleukin Genetics Inc Diagnostics and therapeutics for chronic obstructive airway disease
US6251598B1 (en) * 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis

Similar Documents

Publication Publication Date Title
JP2002533096A5 (enExample)
JP2003500071A5 (enExample)
US7169358B2 (en) Electrochemical detection of nucleic acid sequences
Dunbar Applications of Luminex® xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detection
JP3937136B2 (ja) 塩基多型の検出方法
JP4425142B2 (ja) 遺伝子変異検出法
CA2369045A1 (en) Methods for improving sensitivity and specificity of screening assays
CA2374916A1 (en) Diagnostics and therapeutics for cardiovascular disorders
US20080166710A1 (en) Detection of nucleic acid associated with disease
Syvänen et al. Direct sequencing of affinity‐captured amplified human DNA application to the detection of apolipoprotein E polymorphism
JP2002539848A5 (enExample)
WO1990013668A1 (en) Method for genetic analysis of a nucleic acid sample
US7455975B2 (en) Electrochemical detection of nucleic acid sequences
CN102796828A (zh) 用于检测乙型肝炎病毒的抗药性株系的核酸引物组、测定试剂盒及检测乙型肝炎病毒的抗药性株系的方法
JP2004504802A5 (enExample)
CA2462932A1 (en) Method for the detection of cytosine methylations in immobilized dna samples
JP4410269B2 (ja) N−アセチルトランスフェラーゼ2(nat2)の遺伝子型を検出するための核酸プライマーセット、キット、及び該プライマーセットを用いた検出方法
JP2004500020A (ja) 半導体マイクロチップ上の電子的ドットブロットアッセイによる一塩基多型の識別
JP2007501627A5 (enExample)
EP1612282B1 (en) Probe set and substrate for detecting nucleic acid
AU4766000A (en) Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method
JP2003500067A5 (enExample)
Bang‐Ce et al. Rapid detection of common Chinese glucose‐6‐phosphate dehydrogenase (G6PD) mutations by microarray‐based assay
US20070003938A1 (en) Hybridization of genomic nucleic acid without complexity reduction
Carvalho et al. Optimization of a multiplex minisequencing protocol for population studies and medical genetics